• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-139-5p通过靶向肝癌衍生生长因子抑制非小细胞肺癌的细胞活力、迁移和侵袭并抑制肿瘤生长。

MicroRNA-139-5p inhibits cell viability, migration and invasion and suppresses tumor growth by targeting HDGF in non-small cell lung cancer.

作者信息

Zhang Zuxiong, Li Weizhi, Jiang Damei, Liu Chi, Lai Zhenghong

机构信息

Department of Cardiothoracic Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.

Department of Radiotherapy, Tumor Hospital of Ganzhou, Ganzhou, Jiangxi 341000, P.R. China.

出版信息

Oncol Lett. 2020 Mar;19(3):1806-1814. doi: 10.3892/ol.2020.11296. Epub 2020 Jan 13.

DOI:10.3892/ol.2020.11296
PMID:32194674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7039177/
Abstract

MicroRNA (miRNAs) serve key roles in the progress of various types of cancer. The expression of miRNA (miR)-139-5p is downregulated in several types of tumor and has been recognized as a tumor suppressor. However, the role of miR-139-5p in non-small cell lung cancer (NSCLC) has not been investigated in detail. In the present study, it was demonstrated that miR-139-5p was significantly downregulated in NSCLC cells and tissues, and the overexpression of miR-139-5p induced apoptosis and significantly inhibited the viability and proliferation of A549 and H1299 cells. In addition, upregulation of miR-139-5p significantly inhibited the migration and invasion of A549 and H1299 cells. Hepatoma-derived growth factor (HDGF) was identified as a direct target of miR-139-5p. Rescue experiments demonstrated that the inhibitory function of miR-139-5p on cell viability, migration and invasion was partially mediated by suppressing HDGF expression. Furthermore, miR-139-5p exhibited efficient inhibition of tumor growth in a xenograft tumor mouse model of A549 cells. In summary, the results from the present study suggested that miR-139-5p may serve an important role in NSCLC by targeting HDGF and causing inhibition of cell viability and metastasis, as well as induction of apoptosis. miR-139-5p may also have the potential to serve as a therapeutic target for the treatment of NSCLC.

摘要

微小RNA(miRNA)在各类癌症进展中发挥关键作用。miRNA(miR)-139-5p在多种肿瘤类型中表达下调,并已被确认为一种肿瘤抑制因子。然而,miR-139-5p在非小细胞肺癌(NSCLC)中的作用尚未得到详细研究。在本研究中,结果表明miR-139-5p在NSCLC细胞和组织中显著下调,miR-139-5p的过表达诱导细胞凋亡,并显著抑制A549和H1299细胞的活力和增殖。此外,miR-139-5p的上调显著抑制A549和H1299细胞的迁移和侵袭。肝癌衍生生长因子(HDGF)被鉴定为miR-139-5p的直接靶标。挽救实验表明,miR-139-5p对细胞活力、迁移和侵袭的抑制作用部分是通过抑制HDGF表达介导的。此外,在A549细胞的异种移植肿瘤小鼠模型中,miR-139-5p对肿瘤生长表现出有效的抑制作用。总之,本研究结果表明,miR-139-5p可能通过靶向HDGF并抑制细胞活力和转移以及诱导细胞凋亡,在NSCLC中发挥重要作用。miR-139-5p也有可能成为NSCLC治疗的一个治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/72638ad33b7e/ol-19-03-1806-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/b578500cadf5/ol-19-03-1806-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/b3f65fd5ebe5/ol-19-03-1806-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/d8a54c484b46/ol-19-03-1806-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/29d7889a1201/ol-19-03-1806-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/6078cd9fc782/ol-19-03-1806-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/72638ad33b7e/ol-19-03-1806-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/b578500cadf5/ol-19-03-1806-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/b3f65fd5ebe5/ol-19-03-1806-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/d8a54c484b46/ol-19-03-1806-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/29d7889a1201/ol-19-03-1806-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/6078cd9fc782/ol-19-03-1806-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7d/7039177/72638ad33b7e/ol-19-03-1806-g05.jpg

相似文献

1
MicroRNA-139-5p inhibits cell viability, migration and invasion and suppresses tumor growth by targeting HDGF in non-small cell lung cancer.微小RNA-139-5p通过靶向肝癌衍生生长因子抑制非小细胞肺癌的细胞活力、迁移和侵袭并抑制肿瘤生长。
Oncol Lett. 2020 Mar;19(3):1806-1814. doi: 10.3892/ol.2020.11296. Epub 2020 Jan 13.
2
circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway.环状IARS缺失通过环状IARS/miR-1252-5p/HDGF竞争性内源RNA途径抑制非小细胞肺癌进展。
Open Med (Wars). 2023 Jan 11;18(1):20220613. doi: 10.1515/med-2022-0613. eCollection 2023.
3
MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF.微小RNA-129-5p通过直接靶向肝癌衍生生长因子HDGF,在肝细胞癌中发挥Wnt信号依赖的肿瘤抑制功能。
Cancer Cell Int. 2022 May 16;22(1):192. doi: 10.1186/s12935-022-02582-2.
4
MiR-769-5p, Which Targets , Inhibits Cell Proliferation and Invasion in Nonsmall Cell Lung Cancer.靶向的MiR-769-5p抑制非小细胞肺癌中的细胞增殖和侵袭。
Cancer Biother Radiopharm. 2021 Dec 31. doi: 10.1089/cbr.2021.0363.
5
MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2.miR-7-5p 通过靶向 NOV A2 抑制非小细胞肺癌的肿瘤转移。
Cell Mol Biol Lett. 2019 Nov 20;24:60. doi: 10.1186/s11658-019-0188-3. eCollection 2019.
6
miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.miR-497-5p通过靶向SOX5抑制非小细胞肺癌中的肿瘤细胞生长和侵袭。
J Cell Biochem. 2019 Jun;120(6):10587-10595. doi: 10.1002/jcb.28345. Epub 2019 Feb 28.
7
MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.微小RNA-125a-5p通过直接靶向信号转导和转录激活因子3(STAT3)在肺癌细胞中发挥肿瘤抑制作用。
Tumour Biol. 2017 Jun;39(6):1010428317697579. doi: 10.1177/1010428317697579.
8
MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2.微小 RNA-485-5p 通过靶向 IGF2BP2 抑制非小细胞肺癌细胞的生长和转移。
Life Sci. 2018 Apr 15;199:104-111. doi: 10.1016/j.lfs.2018.03.005. Epub 2018 Mar 3.
9
MicroRNA-873 inhibits the proliferation and invasion of endometrial cancer cells by directly targeting hepatoma-derived growth factor.微小RNA-873通过直接靶向肝癌衍生生长因子来抑制子宫内膜癌细胞的增殖和侵袭。
Exp Ther Med. 2019 Aug;18(2):1291-1298. doi: 10.3892/etm.2019.7713. Epub 2019 Jun 26.
10
Dysregulated Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p.失调通过 miR-19a-3p/miR-19b-3p/miR-125b-5p 促进 NSCLC 的活力和迁移。
DNA Cell Biol. 2022 Mar;41(3):319-329. doi: 10.1089/dna.2021.0900. Epub 2022 Mar 3.

引用本文的文献

1
Defining gastric cancer ecology: the crucial roles of TREM2 macrophages and fibroblasts in tumor microenvironments.定义胃癌生态:TREM2巨噬细胞和成纤维细胞在肿瘤微环境中的关键作用。
Commun Biol. 2025 Mar 28;8(1):514. doi: 10.1038/s42003-025-07512-2.
2
Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC.靶向Nrf2/PHKG2轴以增强非小细胞肺癌的放射敏感性。
NPJ Precis Oncol. 2024 Aug 21;8(1):183. doi: 10.1038/s41698-024-00629-3.
3
PTGR1-mediated immune evasion mechanisms in late-stage triple-negative breast cancer: mechanisms of M2 macrophage infiltration and CD8 T cell suppression.

本文引用的文献

1
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.免疫检查点抑制剂治疗的非小细胞肺癌伴脑膜转移患者的生存情况。
Eur J Cancer. 2019 Jul;116:182-189. doi: 10.1016/j.ejca.2019.05.019. Epub 2019 Jun 13.
2
Functions and mechanisms of microRNA-31 in human cancers.miRNA-31 在人类癌症中的功能和作用机制。
Biomed Pharmacother. 2018 Dec;108:1162-1169. doi: 10.1016/j.biopha.2018.09.132. Epub 2018 Oct 1.
3
Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
PTGR1 介导的晚期三阴性乳腺癌中的免疫逃逸机制:M2 巨噬细胞浸润和 CD8 T 细胞抑制的机制。
Apoptosis. 2024 Dec;29(11-12):2002-2024. doi: 10.1007/s10495-024-01991-0. Epub 2024 Jul 28.
4
Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models.肠道微生物群在去势抵抗性前列腺癌发病机制中的作用:使用测序和动物模型的综合研究。
Oncogene. 2024 Jul;43(31):2373-2388. doi: 10.1038/s41388-024-03073-6. Epub 2024 Jun 17.
5
Identification of Tumor-Suppressive Regulated Genes: as a Therapeutic Target in Lung Adenocarcinoma.肿瘤抑制调控基因的鉴定:作为肺腺癌的治疗靶点
Cancers (Basel). 2023 Nov 24;15(23):5571. doi: 10.3390/cancers15235571.
6
HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer.HDGF通过激活非小细胞肺癌中的PI3K/AKT和MEK/ERK信号通路促进吉非替尼耐药。
Cell Death Discov. 2023 Jun 10;9(1):181. doi: 10.1038/s41420-023-01476-0.
7
circ-IARS depletion inhibits the progression of non-small-cell lung cancer by circ-IARS/miR-1252-5p/HDGF ceRNA pathway.环状IARS缺失通过环状IARS/miR-1252-5p/HDGF竞争性内源RNA途径抑制非小细胞肺癌进展。
Open Med (Wars). 2023 Jan 11;18(1):20220613. doi: 10.1515/med-2022-0613. eCollection 2023.
8
MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.腺癌和鳞状细胞肺癌中的 miRNA 表达谱分析揭示了常见和特定的失调 miRNA。
Medicine (Baltimore). 2022 Aug 19;101(33):e30027. doi: 10.1097/MD.0000000000030027.
9
Regulation of apoptosis, autophagy and ferroptosis by non-coding RNAs in metastatic non-small cell lung cancer (Review).非编码RNA对转移性非小细胞肺癌细胞凋亡、自噬和铁死亡的调控(综述)
Exp Ther Med. 2022 May;23(5):352. doi: 10.3892/etm.2022.11279. Epub 2022 Mar 28.
10
MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin.微小RNA-139-5p靶向调控YAF2并介导AKT/P38丝裂原活化蛋白激酶信号通路以减轻非小细胞肺癌细胞的转移及其对顺铂的耐药性。
Cancer Manag Res. 2021 May 5;13:3639-3650. doi: 10.2147/CMAR.S254671. eCollection 2021.
循环 microRNA-21 表达在食管、胰腺和结直肠癌中的预后意义:系统评价和荟萃分析。
Int J Surg. 2018 Dec;60:41-47. doi: 10.1016/j.ijsu.2018.10.030. Epub 2018 Oct 15.
4
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.肺癌中的 microRNA:作用、机制、途径和治疗相关性。
Mol Aspects Med. 2019 Dec;70:3-20. doi: 10.1016/j.mam.2018.07.003. Epub 2018 Aug 18.
5
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.肝癌衍生生长因子在促进肝细胞癌中新生脂肪生成和肿瘤发生中的作用。
Mol Oncol. 2018 Sep;12(9):1480-1497. doi: 10.1002/1878-0261.12357. Epub 2018 Aug 7.
6
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study.纳武利尤单抗治疗经治晚期非小细胞肺癌的 5 年随访结果:CA209-003 研究结果。
J Clin Oncol. 2018 Jun 10;36(17):1675-1684. doi: 10.1200/JCO.2017.77.0412. Epub 2018 Mar 23.
7
MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.微小 RNA 对胰腺癌中 K-Ras 的调控及治疗干预的机会。
Semin Cancer Biol. 2019 Feb;54:63-71. doi: 10.1016/j.semcancer.2017.11.020. Epub 2017 Dec 2.
8
Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.肝癌衍生生长因子:其可能参与肝细胞癌的进展
Int J Mol Sci. 2015 Jun 19;16(6):14086-97. doi: 10.3390/ijms160614086.
9
Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer.非小细胞肺癌中的生存、分类和桥粒斑蛋白基因。
Int J Med Sci. 2013 Jul 10;10(9):1166-73. doi: 10.7150/ijms.5747. Print 2013.
10
Downregulation of EIF4A2 in non-small-cell lung cancer associates with poor prognosis.EIF4A2 在非小细胞肺癌中的下调与不良预后相关。
Clin Lung Cancer. 2013 Nov;14(6):658-65. doi: 10.1016/j.cllc.2013.04.011. Epub 2013 Jul 16.